NCM · Biotechnology

CURX (CURX) Stock

$0.18 -2.61% NCM: CURX Healthcare

Valuation

MetricValue
Price$0.18
Market Cap$5.19M
P/E Ratio-1.94
P/B Ratio0.86
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$9.18
52-Week Low$0.18
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-36.36%
ROA-33.33%
ROCE-33.33%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.04
Current Ratio0.00

Annual Financials (USD)

Metric2022202320242025
Revenue$0$0$0$0
Operating Profit$0$0$0$-4.0M
Net Profit$0$0$0$-4.0M
EPS$-0.02$0.00$-0.01$-0.17
Op Margin-77.8%———

Balance Sheet (USD)

Metric2022202320242025
Total Assets—$0$1.0M$12.0M
Total Liabilities—$0$0$0
Cash—$0$0$5.0M
Borrowings$0$0$0$0

Latest News

Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission GlobeNewswire · May 14, 2026

Cash Flow (USD)

Metric2022202320242025
Operating Cash Flow—$0$-1.0M$-10.0M
Investing Cash Flow—$0$0$0
Financing Cash Flow—$0$0$15.0M
Net Cash Flow—$0$0$5.0M
Free Cash Flow$0$0$-1.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-120.16%
Quick Ratio62.87
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held67.82%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ASBP $7.26 +3.13% -0.74 $837601 0.00%
BCTX $3.53 +1.73% -0.04 $6.65M 0.00%
CRIS $4.69 -4.09% -0.35 $9.14M 0.00%
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares $3.04 -8.43% -2.11 $8.15M 0.00%
DARE $1.32 +3.13% -1.94 $12.57M 0.00%

About CURX

CURX is led by CEO Jun Liu, headquartered in US, publicly traded since 2025.

CURX stock trades at $0.18 with a market capitalization of $5.19M. The stock is valued at a price-to-earnings (P/E) ratio of -1.94, price-to-book of 0.86, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.18 and $9.18, and currently trades 98.0% below its 52-week high.

On profitability, CURX generates a return on equity (ROE) of -36.36%, return on capital employed of -33.33%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides